Brainsway Ltd. Sponsored ADR (NASDAQ:BWAY – Get Free Report) was the target of a large increase in short interest in August. As of August 31st, there was short interest totaling 191,700 shares, an increase of 191.8% from the August 15th total of 65,700 shares. Currently, 1.3% of the shares of the stock are sold short. Based on an average daily trading volume, of 64,200 shares, the short-interest ratio is currently 3.0 days. Based on an average daily trading volume, of 64,200 shares, the short-interest ratio is currently 3.0 days. Currently, 1.3% of the shares of the stock are sold short.
Wall Street Analyst Weigh In
A number of analysts have recently commented on the company. Northland Securities upped their price target on Brainsway from $15.00 to $19.00 and gave the company an “outperform” rating in a research note on Thursday, August 14th. Wall Street Zen raised Brainsway from a “hold” rating to a “buy” rating in a research note on Sunday, August 17th. Finally, HC Wainwright reissued a “buy” rating and set a $17.00 target price on shares of Brainsway in a research note on Monday, August 25th. Two investment analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, the company currently has an average rating of “Buy” and an average price target of $18.00.
Get Brainsway alerts:
Check Out Our Latest Stock Analysis on BWAY
Brainsway Stock Up 0.4%
Shares of BWAY opened at $15.77 on Monday. The stock has a market capitalization of $298.05 million, a P/E ratio of 60.66 and a beta of 1.33. Brainsway has a twelve month low of $7.84 and a twelve month high of $16.25. The company has a 50 day moving average of $13.48 and a 200-day moving average of $11.21.
Brainsway (NASDAQ:BWAY – Get Free Report) last released its quarterly earnings data on Wednesday, August 13th. The company reported $0.10 EPS for the quarter, beating the consensus estimate of $0.07 by $0.03. Brainsway had a return on equity of 8.97% and a net margin of 11.60%.The company had revenue of $12.63 million during the quarter, compared to the consensus estimate of $12.34 million. Brainsway has set its FY 2025 guidance at EPS. On average, sell-side analysts anticipate that Brainsway will post 0.08 earnings per share for the current fiscal year.
Hedge Funds Weigh In On Brainsway
Several hedge funds have recently bought and sold shares of the company. Cubist Systematic Strategies LLC grew its position in Brainsway by 14.6% in the fourth quarter. Cubist Systematic Strategies LLC now owns 19,228 shares of the company’s stock valued at $181,000 after acquiring an additional 2,446 shares during the last quarter. Lazard Asset Management LLC bought a new stake in Brainsway in the fourth quarter valued at approximately $44,000. Two Sigma Investments LP boosted its holdings in Brainsway by 2.0% in the fourth quarter. Two Sigma Investments LP now owns 92,755 shares of the company’s stock valued at $875,000 after acquiring an additional 1,786 shares during the last quarter. Two Sigma Advisers LP lifted its stake in Brainsway by 32.6% in the fourth quarter. Two Sigma Advisers LP now owns 60,600 shares of the company’s stock valued at $571,000 after buying an additional 14,900 shares during the period. Finally, Valor Management LLC acquired a new position in Brainsway in the fourth quarter valued at approximately $19,838,000. 30.11% of the stock is owned by institutional investors.
About Brainsway
(Get Free Report)
BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer’s disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson’s diseases.
Featured Stories
Five stocks we like better than Brainsway
ETF Screener: Uses and Step-by-Step Guide
Best Bang For Your Buck? 2 Bargain Stocks with 30%+ Upside
Where to Find Earnings Call Transcripts
Football Season Is Here and DraftKings Stock Is Surging
What Investors Need to Know to Beat the Market
RH Stock Slides After Mixed Earnings and Tariff Concerns